CA2303176A1 - Derives de pyrrolopyrrolone en tant qu'inhibiteurs de neutrophile elastase - Google Patents

Derives de pyrrolopyrrolone en tant qu'inhibiteurs de neutrophile elastase Download PDF

Info

Publication number
CA2303176A1
CA2303176A1 CA002303176A CA2303176A CA2303176A1 CA 2303176 A1 CA2303176 A1 CA 2303176A1 CA 002303176 A CA002303176 A CA 002303176A CA 2303176 A CA2303176 A CA 2303176A CA 2303176 A1 CA2303176 A1 CA 2303176A1
Authority
CA
Canada
Prior art keywords
isopropyl
hexahydro
carbonyl
methanesulfonyl
pyrrolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002303176A
Other languages
English (en)
Inventor
Geoffrey Duke Edward Clarke
Michael Dennis Dowle
Harry Finch
Lee Andrew Harrison
Graham George Adam Inglis
Martin Redpath Johnson
Simon John Fawcett Macdonald
Pritom Shah
Robin Andrew Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9719189.4A external-priority patent/GB9719189D0/en
Priority claimed from GBGB9719183.7A external-priority patent/GB9719183D0/en
Priority claimed from GBGB9719290.0A external-priority patent/GB9719290D0/en
Priority claimed from GBGB9803611.4A external-priority patent/GB9803611D0/en
Application filed by Individual filed Critical Individual
Publication of CA2303176A1 publication Critical patent/CA2303176A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

L'invention concerne des composés représentés par la formule (I) dans laquelle R?1¿, R?2¿ et R?3¿ sont tels qu'ils sont définis dans le descriptif. Ces composés sont utiles notamment pour traiter des maladies inflammatoires des voies respiratoires.
CA002303176A 1997-09-09 1998-09-07 Derives de pyrrolopyrrolone en tant qu'inhibiteurs de neutrophile elastase Abandoned CA2303176A1 (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GBGB9719189.4A GB9719189D0 (en) 1997-09-09 1997-09-09 New therapeutic method
GB9719183.7 1997-09-09
GB9719189.4 1997-09-09
GBGB9719183.7A GB9719183D0 (en) 1997-09-09 1997-09-09 Compounds
GBGB9719290.0A GB9719290D0 (en) 1997-09-10 1997-09-10 Compounds
GB9719290.0 1997-09-10
GB9803611.4 1998-02-21
GBGB9803611.4A GB9803611D0 (en) 1998-02-21 1998-02-21 Compounds
PCT/EP1998/005609 WO1999012933A2 (fr) 1997-09-09 1998-09-07 Derives de pyrrolopyrrolone en tant qu'inhibiteurs de neutrophile elastase

Publications (1)

Publication Number Publication Date
CA2303176A1 true CA2303176A1 (fr) 1999-03-18

Family

ID=27451698

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002303176A Abandoned CA2303176A1 (fr) 1997-09-09 1998-09-07 Derives de pyrrolopyrrolone en tant qu'inhibiteurs de neutrophile elastase

Country Status (24)

Country Link
EP (1) EP1003748A2 (fr)
JP (1) JP2001515904A (fr)
KR (1) KR20010023766A (fr)
CN (1) CN1278820A (fr)
AP (1) AP2000001761A0 (fr)
AR (1) AR017072A1 (fr)
AU (1) AU9741298A (fr)
BR (1) BR9812062A (fr)
CA (1) CA2303176A1 (fr)
CO (1) CO4970719A1 (fr)
EA (1) EA200000204A1 (fr)
EE (1) EE200000138A (fr)
HU (1) HUP0004644A3 (fr)
ID (1) ID24452A (fr)
IL (1) IL134791A0 (fr)
IS (1) IS5391A (fr)
MA (1) MA26543A1 (fr)
NO (1) NO20001198L (fr)
NZ (1) NZ503130A (fr)
PE (1) PE107899A1 (fr)
PL (1) PL339176A1 (fr)
SK (1) SK3192000A3 (fr)
TR (1) TR200000907T2 (fr)
WO (1) WO1999012933A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9905418D0 (en) * 1999-03-09 1999-05-05 Glaxo Group Ltd Process
ATE490959T1 (de) 2004-03-31 2010-12-15 Janssen Pharmaceutica Nv Heterocyclische nichtimidazolverbindungen als modulatoren des histamin-h3-rezeptors
DE102004024772A1 (de) * 2004-05-17 2005-12-22 Grünenthal GmbH Substituierte 5-Aminomethyl-1H-pyrrol-2-carbonsäureamide
TWI355380B (en) 2004-05-27 2012-01-01 Nihon Nohyaku Co Ltd Substituted pyrazinecarboxanilide derivatives or s
JP4853759B2 (ja) * 2004-05-27 2012-01-11 日本農薬株式会社 置換ピラジンカルボン酸アニリド誘導体又はその塩類、その中間体及び農園芸用薬剤並びにその使用方法
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
AP2007003979A0 (en) 2004-11-23 2007-06-30 Warner Lambert Co 7-(2h-pyrazol-3-yl)-3,5-dihyroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for thetreatment of lipidemia
US8198288B2 (en) 2006-05-04 2012-06-12 Pulmagen Therapeutics (Inflammation) Limited Tetrahydropyrrolopyrimidinediones and their use in therapy
DE602007009095D1 (de) 2006-05-04 2010-10-21 Pulmagen Therapeutics Inflamma Tetrahydropyrrolopyrimidindione und ihre verwendung als inhibitoren der humanen neutrophilen elastase
GB2452696B (en) 2007-08-02 2009-09-23 Cambridge Entpr Ltd 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
US7662967B2 (en) 2007-08-02 2010-02-16 Cambridge Enterprise Limited Anti-inflammatory compounds and compositions
WO2009060206A1 (fr) * 2007-11-07 2009-05-14 Argenta Discovery Limited 3,4,6,7-tétrahydro-1h-pyrrolo[3,4-d]pyrimidine-2,5-diones et leur utilisation thérapeutique
US20110212181A1 (en) * 2010-02-26 2011-09-01 The University Of Hong Kong Compositions and methods for treating chronic respiratory inflammation
JP7672641B2 (ja) 2019-09-17 2025-05-08 メレオ バイオファーマ ４ リミテッド 移植片拒絶反応、閉塞性細気管支炎症候群、及び移植片対宿主病の治療に使用するためのアルベレスタット
IL297211B2 (en) 2020-04-16 2025-12-01 Mereo Biopharma 4 Ltd Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
KR20240090272A (ko) 2021-10-20 2024-06-21 메레오 바이오파마 4 리미티드 섬유화 치료에 사용하기 위한 호중구 엘라스테이스 억제제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
CA2250209A1 (fr) * 1996-03-28 1997-10-09 Glaxo Group Limited Derives du pyrrolopyrrolone utilises comme inhibiteurs de l'elastase de neutrophiles

Also Published As

Publication number Publication date
TR200000907T2 (tr) 2000-11-21
PE107899A1 (es) 1999-11-17
CO4970719A1 (es) 2000-11-07
AU9741298A (en) 1999-03-29
ID24452A (id) 2000-07-20
EE200000138A (et) 2001-02-15
MA26543A1 (fr) 2004-12-20
PL339176A1 (en) 2000-12-04
WO1999012933A2 (fr) 1999-03-18
AP2000001761A0 (en) 2000-03-31
IL134791A0 (en) 2001-04-30
SK3192000A3 (en) 2001-03-12
WO1999012933A3 (fr) 1999-05-27
JP2001515904A (ja) 2001-09-25
AR017072A1 (es) 2001-08-22
NZ503130A (en) 2001-08-31
IS5391A (is) 2000-02-29
BR9812062A (pt) 2000-09-26
HUP0004644A3 (en) 2002-01-28
NO20001198L (no) 2000-05-08
CN1278820A (zh) 2001-01-03
HUP0004644A2 (hu) 2001-09-28
EP1003748A2 (fr) 2000-05-31
KR20010023766A (ko) 2001-03-26
EA200000204A1 (ru) 2000-10-30
NO20001198D0 (no) 2000-03-08

Similar Documents

Publication Publication Date Title
CA2303176A1 (fr) Derives de pyrrolopyrrolone en tant qu'inhibiteurs de neutrophile elastase
US5994344A (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
CA2683695A1 (fr) Nouveaux derives de 3-amido-pyrrolo[3,4-c]pyrazole-5(1h,4h.6h) carbaldehyde
CN101605798A (zh) 咪唑并噻唑衍生物
CA2210093A1 (fr) Agents anticancereux a base de cyclopropylpyrrolo-indole-oligopeptides
WO2015043364A1 (fr) Composé de benzoxazoléoxazine cétone comme inhibiteur du facteur de coagulation sanguine xa
US6228853B1 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
KR101577314B1 (ko) 키나제 억제제로서의 접합된 티아졸 유도체
CN119317620A (zh) 氮杂环烷基羰基环状胺化合物
US6177425B1 (en) Pyrrolopyrrolone derivatives
WO2000018770A1 (fr) Derives de pyrrolopyrrolone comme agents antiviraux
MXPA00002325A (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
CZ2000877A3 (cs) Pyrrolopyrrolonové deriváty
CN120569201A (zh) 用于治疗炎性疾病的组合物和方法
WO2024041586A1 (fr) Promédicament d'inhibiteur de kinase jak
JP2001515903A (ja) セリンプロテアーゼ酵素の阻害方法
WO2010146351A1 (fr) Derives d'indolylmethyl-morpholine en tant qu'inhibiteurs des kinases
CZ2000878A3 (cs) Pyrrolopyrrolonové deriváty

Legal Events

Date Code Title Description
FZDE Discontinued